Skip to main content
Werewolf Therapeutics, Inc. logo

Werewolf Therapeutics, Inc. — Investor Relations & Filings

Ticker · HOWL ISIN · US95075A1079 US Manufacturing
Open in API
Filings indexed 367 across all filing types
Latest filing 2023-04-27 Proxy Solicitation & In…
Country US United States of America
Listing US HOWL

About Werewolf Therapeutics, Inc.

https://werewolftx.com/

Werewolf Therapeutics, Inc. is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company utilizes its proprietary PREDATOR® protein engineering platform to create a novel class of conditionally activated proinflammatory immune modulators, known as INDUKINE™ and INDUCER™ molecules. These therapies are designed to be delivered systemically in an inactive state and become selectively activated within the tumor microenvironment. This approach aims to generate a potent, localized anti-tumor immune response while minimizing the systemic side effects associated with conventional immunotherapies. The company's pipeline includes clinical-stage candidates such as WTX-124 and WTX-330.

Recent filings

Filing Released Lang Actions
DEF 14A
Proxy Solicitation & Information Statement
2023-04-27 English
S-8
Regulatory Filings Classification · 100% confidence The document is a Form S-8 Registration Statement filed with the SEC, which is used to register securities under employee benefit plans such as stock incentive plans and employee stock purchase plans. It includes details about the plans, incorporation by reference of previous filings, exhibits, and signatures of officers and directors. This type of filing is related to the registration of securities for employee compensation plans and does not fit into categories like Annual Report, Earnings Release, or Management Reports. It is a regulatory filing specific to securities registration under the Securities Act of 1933. Therefore, the most appropriate classification is Regulatory Filings (RNS). The document length and content confirm it is not a brief announcement or a report publication announcement but a full registration statement.
2023-03-23 English
10-K
Annual Report FY 2022
2023-03-23 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce material events. The text specifically mentions that the company issued a press release announcing financial results for the quarter ended December 31, 2022, and that the press release is furnished as an exhibit. The document itself does not contain detailed financial statements or substantive financial data but rather references the press release. The length is 3783 characters, which is relatively short and consistent with an announcement rather than a full report. According to the rules, such a document is best classified as a Regulatory Filing (RNS) because it is a current report announcing financial results but not the full earnings release or quarterly report itself. The press release is attached as an exhibit, so this is not the earnings release (ER) itself but a regulatory filing announcing it.
2023-03-23 English
8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes the entry into a material definitive agreement, specifically an amendment to a loan and security agreement. There are no financial statements or detailed financial data presented, only a description of the amendment and a reference to the attached exhibit. The document length is 3707 characters, which is relatively short and consistent with a regulatory announcement rather than a full financial report. This fits the category of Capital/Financing Update (CAP), as it relates to changes in financing agreements and capital structure. It is not an Annual Report, Interim Report, or Earnings Release, nor is it a report publication announcement or regulatory filing of a different nature. Therefore, the appropriate classification is CAP with high confidence.
2023-03-22 English
SC 13G
Major Shareholding Notification
2023-02-10 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.